Laverock Therapeutics Limited - Period Ending 2022-12-31
Laverock Therapeutics Limited - Period Ending 2022-12-31
Registration number:
Laverock Therapeutics Limited
for the Period from 13 July 2021 to 31 December 2022
Laverock Therapeutics Limited
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Unaudited Financial Statements |
Laverock Therapeutics Limited
Company Information
|
Directors |
Gilad Gershon Elsy Boglioli John Robert Brown Erez Vigodman David Charles Venables |
|
Company secretary |
Rosheen Caw |
|
Registered office |
|
|
Accountants |
|
Laverock Therapeutics Limited
(Registration number: 13508159)
Balance Sheet as at 31 December 2022
|
2022 |
|
|
Fixed assets |
|
|
Current assets |
|
|
Prepayments and accrued income |
|
|
Creditors: Amounts falling due within one year |
( |
|
Net current assets |
|
|
Total assets less current liabilities |
|
|
Creditors: Amounts falling due after more than one year |
( |
|
Accruals and deferred income |
( |
|
( |
|
|
Capital and reserves |
( |
|
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
England
These financial statements were authorised for issue by the
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.
|
Staff numbers |
The average number of persons employed by the company (including directors) during the period, was
For the financial period ending 31 December 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
Laverock Therapeutics Limited
(Registration number: 13508159)
Balance Sheet as at 31 December 2022
|
• |
|
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved and authorised by the
|
......................................... |